FDA Enforcement Class II Terminated

00595501201 Provisional CR-FLEX FEM PROV SZ B-L, Rx, Sterile; 00595501202 Provisional CR-FLEX FEM PROV SZ B-R, Rx, Sterile; Used in total knee arthroplasty and indicated for patients with severe pain.

Recall: Z-2035-2013 · Reported August 28, 2013

Enforcement

Recall Number
Z-2035-2013
Event ID
65413
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Zimmer, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Report Date
August 28, 2013
Initiation Date
June 7, 2013
Classification Date
August 22, 2013
Termination Date
December 15, 2014
Address
345 E Main St, N/A, Warsaw, IN, 46580-2746, United States

Description

00595501201 Provisional CR-FLEX FEM PROV SZ B-L, Rx, Sterile; 00595501202 Provisional CR-FLEX FEM PROV SZ B-R, Rx, Sterile; Used in total knee arthroplasty and indicated for patients with severe pain.

Reason

Surgeons are implanting components of the NexGen Cruciate Retaining (CR) Complete Knee System in combinations that are not approved (micro with standard). Includes CR Micro Femurs, Articular Surface, Patellae, instruments and provisionals combined with standard components. A March 2012 recall reiterated the proper combination labeling, but the mis match problem continues. Zimmer is removing the d

Code Info

all codes

Distribution

Worldwide Distribution-USA (nationwide) and the country of Japan.

Quantity

192,355 all devices